Activation of NF-κB has been implicated in the development of a number of human malignancies, and it appears to be important for the survival of cancer cells, as well as the conferring of more aggressive tumor phenotype and resistance to drug therapies [43-46]. This evidence concerns the gene NFKB1 and neoplasm.